Skip to content

Culturally Adapted Parenting Intervention for Spanish-Speaking Parents in Improving Outcomes of Younger Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia Survivors at Risk for Late Neurocognitive Effects

Adaptation and Pilot-Testing a Parenting Intervention for Spanish-Speaking Parents of Children at Risk for Neurocognitive Late Effects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02559557
Enrollment
38
Registered
2015-09-24
Start date
2015-10-22
Completion date
2016-04-18
Last updated
2021-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Survivor, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Cognitive Side Effects of Cancer Therapy

Brief summary

This pilot clinical trial studies a culturally adapted skills training and educational intervention in guiding parents of younger acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) survivors at risk for long-term attention and memory problems (late neurocognitive effects). ALL and AML treatments target the central nervous system and may put younger survivors at increased risk for late neurocognitive effects, which may lead to learning difficulties or behavior problems and poor health-related quality of life. Spanish-speaking parents of young ALL or AML survivors may not have access to the information, resources, or guidance to help their children through these difficulties. Adapting an existing parent-training program into Spanish may help teach Spanish-speaking parents effective ways to prevent or reduce learning and behavioral difficulties, which may improve the quality of life of parents and young ALL or AML survivors.

Detailed description

PRIMARY OBJECTIVES: I. To culturally modify and adapt an existing educational and skills-training intervention for use with Spanish-speaking parents of children with acute lymphoblastic leukemia (ALL) or with acute myeloid leukemia (AML). II. To pilot the culturally-modified, parenting intervention with eligible families of children treated for ALL or AML in the Pediatrics department at City of Hope. OUTLINE: PHASE I (FOCUS GROUPS): Parents undergo a semi-structured interview with bilingual research assistants over 120 minutes. The content and purpose of the intervention is explained, and the focus group discussions elicit feedback on the intervention components and content of the sessions, and whether the material is culturally and linguistically appropriate. Following the focus group discussion, parents receive a copy of the educational handouts that they may choose to use with their child if they like. PHASE II (PILOT TESTING): Parents of children age 5 to 17 years, 11 months old undergo adapted skills training in Spanish over 60 minutes (8 training sessions total) or 80 minutes (6 training sessions total). The adapted skills training sessions focus on parenting strategies and learning techniques. Sessions include homework assignments and techniques for parents to apply with their child for at least 30 minutes, 3 times a week at home. After completion of study, parents are followed up every 2 weeks for 3 months and at 6 and 12 months.

Interventions

OTHEREducational Intervention

Participate in focus groups

OTHERQuality-of-Life Assessment

Answer questionnaires

OTHERQuestionnaire Administration

Answer questionnaires

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
City of Hope Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

INCLUSION CRITERIA FOR FOCUS GROUPS (PHASE I) * Parents or adult primary caregiver (e.g., grandmother) of children ages 5 to 17 in treatment remission and has completed intensive therapy for ALL or AML * Parents of childhood cancer survivors who are now 18 years or older and who were previously treated for ALL or AML (do not need to live with the child) * One or both of the parents will self-identify as Hispanic/Latino, the primary participating parent will be either Spanish speaking, bilingual, or is bilingual but identifies their primary language as English and will live with the child INCLUSION CRITERIA FOR PILOT-TESTING (PHASE II) * Parent/Caregiver: parents or adult primary caregiver (e.g., grandmother) of children treated for ALL or AML * Parent/Caregiver: one or both of the parents will self-identify as Hispanic/Latino, the primary participating parent will be either Spanish speaking, bilingual, or is bilingual but identifies their primary language as English and will live with the child * Child: child is in treatment remission and has completed intensive therapy * Child: child is age 5 to 17 years, 11 months * Child: child understands English

Design outcomes

Primary

MeasureTime frameDescription
Feasibility, measured by the percentage of parents who complete the entire adapted skills-training parenting interventionAfter 6 sessions (up to 12 months)Feasibility will be operationally defined as \> 75% of parents completing the intervention.

Secondary

MeasureTime frameDescription
Change in child's school-related health-related quality of life (HRQOL) score as assessed by the Pediatric Quality of Life scaleBaseline to up to 12 monthsExplored for pre- and post-intervention changes using descriptive analyses.
Change in learning strategies as measured by the School Motivation and Learning Strategies InventoryBaseline to up to 12 monthsExplored for pre- and post-intervention changes using descriptive analyses.
Change in parent knowledge and efficacy, as measured by the Parent Knowledge, Beliefs, and Behaviors Questionnaire (PBQ)Baseline to up to 12 monthsExplored for pre- and post-intervention changes using descriptive analyses.
Parent satisfaction with the intervention as measured by the perceived benefits scaleUp to 12 monthsSatisfaction with intervention is defined as group mean rating of \> 3/5 on the perceived benefit scale. Perceived benefit will be examined using group means obtained from parents' ratings on satisfaction and barriers questionnaires.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026